BioNTech Aktie
WKN DE: A2PSR2 / ISIN: US09075V1026
|
07.05.2026 13:00:02
|
BioNTech Board Authorizes $1 Bln ADS Repurchase Program
(RTTNews) - Thursday, BioNTech SE (BNTX) announced that its board has authorized a new program to repurchase American Depositary Shares or ADS for an aggregate amount of up to $1.0 billion.
The company intends to use the repurchased ADSs to satisfy obligations in the ordinary course of business. Also, it believes that the program is consistent with the company's capital allocation strategy as well as its commitment to sustainable value creation for the shareholders.
Repurchases under the program may be made until and including May 6, 2027.
In the pre-market hours, BNTX is trading at $95.34, up 0.09 percent on the Nasdaq.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu BioNTech (ADRs)
Analysen zu BioNTech (ADRs)
| 13.04.26 | BioNTech Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 25.03.26 | BioNTech Buy | Jefferies & Company Inc. | |
| 17.03.26 | BioNTech Buy | Deutsche Bank AG | |
| 11.03.26 | BioNTech Buy | Goldman Sachs Group Inc. | |
| 10.03.26 | BioNTech Buy | Jefferies & Company Inc. |
Aktien in diesem Artikel
| BioNTech (ADRs) | 79,65 | 0,50% |
|
Letzte Top-Ranking Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.